Nucletron ontvangt 510(k) FDA Clearance for Oncentra® RT Viewer
ArrayNucletron uit Veenendaal heeft onlangs een FDA approval gekregen voor het reviewing systeem voor radiotherapy. De planning van het systeem is DICOM-compliant in een Windows (PC) environment.”
Lees hieronder het engelse persbericht van Nucletron.
Nucletron, a knowledge-based leader in radiation oncology, announced today that it has received 510(k) clearance from the Food and Drug Administration (FDA) on Oncentra® RT Viewer, its latest innovation in their Oncentra family of treatment planning solutions. FDA clearance now allows Nucletron to provide Oncentra RT Viewer to its U.S. customers, enabling clinicians to review radiotherapy plans generated with a wide variety of DICOM-compliant treatment planning systems in a Windows (PC) environment.
“Oncentra RT Viewer has several robust features that enable clinicians to work more efficiently in a digital environment,†said Bill Dowd, Nucletron’s vice president for North America. “The application puts powerful tools in the hands of clinicians during the treatment planning stage. Oncentra RT Viewer powers true interoperability between planning facilities regardless of treatment plan origin. This is a novel and exciting development for radiation treatment workflow. â€
Oncentra RT Viewer makes it possible to review and share treatment planning data such as DICOM RT images, RT structure sets, RT plans including RT dose on any computer, making it an optimal tool for clinical consulting and peer-to-peer reviewing. Oncentra RT Viewer is a technologically advanced alternative to hardcopy paper information for reviewing and sharing treatment planning data, and utilizes the hospital network for sharing plans digitally, as well as on any other electronic sharing device.
